Background: DSM-5 introduced the anxious distress specifier in recognition of the clinical significance of anxiety in depressed patients. Recent studies that supported the validity of the specifier did not use measures that were designed to assess the criteria of the specifier but instead approximated the DSM-5 criteria from scales that were part of an existing data base. In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we examined the validity of the specifier diagnosed with a semistructured interview.
INTRODUCTION
Compared to depressed patients without anxiety, depressed patients with high levels of anxiety are characterized by higher levels of suicidal ideation and history of suicide attempts (Fava, Rush, Alpert, & Carmin, 2006; Goes, McCusker, Bienvenu, & Mackinnon, 2010; Sareen, Cox, Afifi, & de Graaf, 2005; Seo, Jung, Kim, & Kim, 2011) , poorer functioning (Fichter, Quadflieg, Fischer, & Kohlboeck, 2010; Lin, Wang, Lin, & Chen, 2014) , poorer health-related quality of life (Lin et al., 2014; Rhebergen, Batelaan, de Graaf, & Nolen, 2011) , and greater chronicity (Brown, Schulberg, & Prigerson, 2000; Coryell, Endicott, Andreasen, & Keller, 1988; Fichter et al., 2010; Gaynes, Magruder, Burns, & Wagner, 1999; Grunhaus, 1988; Melartin, Rytsala, Leskela, & Lestela-Mielonen, 2004 ; Rhebergen et al., 2011; Shankman & Klein, 2002; Sherbourne & Wells, 1997; Van Valkenburg, Winokur, Behar, & Lowry, 1984) . In recognition of the clinical significance of anxiety in depressed patients, DSM-5 introduced the anxious distress specifier as a method of subtyping major depressive disorder (MDD).
A few recent studies have supported the validity of the specifier, however, they did not use measures that were designed to assess the criteria of the specifier, but instead these studies approximated the DSM-5 criteria from scales that were part of an already existing data base (Gaspersz, Lamers, Kent, & Beekman, 2017a , 2017b McIntyre, Weiller, Zhang, & Weiss, 2016; McIntyre, Woldeyohannes, Soczynska, & Vinberg, 2016; Melca, Yucel, Mendlowicz, & de Oliveira-Souza, 2015; Shim, Woo, & Bahk, 2016) . In some of these studies, not all the criteria were assessed c 2018 Wiley Periodicals, Inc. 31 wileyonlinelibrary.com/journal/da studies, the authors noted that some of the proxy items may not have been accurate representations of the DSM-5 criterion (Gaspersz et al., 2017a (Gaspersz et al., , 2017b . Moreover, in each of these studies, the proxy assessment of the DSM-5 criteria was cross-sectional based on symptom presence during the past week. The DSM-5 definition, on the other hand, requires the criteria to be present for the majority of the depressive episode. Thus, the relationship between these approximations and the DSM-5 criteria is uncertain.
We previously described the reliability and validity of the DSM-5 Anxious Distress Specifier Interview (DADSI) (Zimmerman, Clark, McGonigal, & Harris, 2017) . In that paper, we examined the reliability of the DADSI, the psychometric properties of the DSM-5 criteria, the correlation between DADSI scores and measures of anxiety and depression, and mean DADSI scores in patients with and without various anxiety disorders. Thus, we predominantly examined the DSM-5 anxious distress specifier from a dimensional perspective (i.e., continuous distribution of total severity scores). In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we examined the validity of the specifier from a categorical perspective (i.e., dichotomous determination of specifier presence or absence). Specifically, we tested the hypothesis that the depressed patients who met the anxious distress specifier criteria would have an increased frequency of anxiety disorders, greater suicidality, poorer coping ability, lower levels of life satisfaction, greater functional impairment, and a more chronic course compared to patients who did not meet the criteria for the specifier.
We also examined whether the anxious distress specifier was independently associated with these variables after controlling for the presence of a DSM anxiety disorder. Because the anxious distress specifier is a new diagnostic construct, it is important to examine if it adds incremental validity beyond previous diagnostic conceptualizations. That is, if assignment of the diagnostic specifier fails to show incremental validity beyond existing DSM-based diagnoses (e.g., major depression with a comorbid anxiety disorder), then it is more difficult to justify its addition to the DSM. Specifically, if the anxious distress specifier is not independently associated with these variables after first accounting for the presence of an anxiety disorder, then why add another diagnostic distinction to the DSM. On the other hand, improved clinical utility (First, Pincus, Levine, & Williams, 2004) , as opposed to validity, could be a justification for inclusion in the DSM.
Because it takes less time to assess the anxious distress specifier than determining the presence or absence of each of the anxiety disorders, then one could justify the specifier's inclusion in DSM-5 if it accounts for the variance in clinically significant variables that is accounted for by the anxiety disorders. Thus, we also examined if anxiety disorders were associated with these variables after first controlling for the anxious distress specification.
METHODS
Two hundred sixty patients with a principal diagnosis of current DSM-IV/DSM-5 MDD presenting for an intake evaluation at the Rhode Island Hospital Department of Psychiatry partial hospital program were interviewed by a trained diagnostic rater. The Rhode Island Hospital institutional review committee approved the research protocol, and all patients provided informed written consent. The patients included in our prior report on the DSM-5 anxious distress specifier . Additional questions were included, as needed, to rate the items on the 17-item Hamilton Depression Rating Scale (HAMD) (Hamilton, 1960) and Hamilton Anxiety Rating Scale (Hamilton, 1959) . From the HAMD, we computed scores on the anxiety/somatization factor. The HAMD anxiety-somatization factor was derived from a factor analysis of the scale (Cleary & Guy, 1977) and includes items assessing psychic anxiety, somatic anxiety, hypochondriacal fears, gastrointestinal symptoms including poor appetite, other somatic symptoms including pain and fatigue, and poor insight. We also computed scores on the HAMD melancholia factor.
The DSM-5 specifier requires the presence of at least two of the five criterion symptoms for the majority of the depressive episode. The five symptoms of the anxious distress specifier are as follows: feeling keyed up or tense, feeling restless, difficulty concentrating because of worry, fear that something awful might happen, and feeling that one might lose control. The probes of the DADSI inquire about symptom presence and severity for the past week and also determine if the symptom is present for the majority of the depressive episode.
The joint-interview interrater reliability of the DADSI was examined in 25 patients . The reliability of the total scale dimensional score was high (ICC = 0.93), as was the reliability of anxious distress subtyping (kappa = 1.00). The test-retest interrater reliability of the DADSI was examined in a separate subsample of 25 patients. The test-retest reliability of the total scale dimensional score was excellent (ICC = 0.80), and the reliability of anxious distress subtyping was good (kappa = 0.60).
The patients completed the Clinically Useful Depression Outcome Scale (CUDOS) (Zimmerman, Chelminski, McGlinchey, & Posternak, 2008), the Clinically Useful Anxiety Outcome Scale (CUXOS) (Zimmerman, Chelminski, Young, & Dalrymple, 2010) , the Clinically Useful Anger Outcome Scale (CUANGOS) (Zimmerman, in preparation) , and the Remission from Depression Questionnaire (RDQ) (Zimmerman, Galione, Attiullah, & Friedman, 2011; Zimmerman, Martinez, Attiullah, & Friedman, 2013) . The self-report scales were completed prior to the diagnostic interview or later that day. The ratings on the DADSI were made blind to the results of the self-report scales.
The CUDOS contains 16 items assessing all of the DSM-IV inclusion criteria for MDD (Zimmerman et al., 2008) . The respondent is instructed to rate the 16 symptom items on a 5-point ordinal scale indicating "how well the item describes you during the past week, including today." Total scores range from 0 to 64. In the present study, the internal consistency of the CUDOS was 0.78.
The CUXOS is a general measure of psychic and somatic anxiety rather than a disorder-specific scale. The respondent is instructed to rate the 20 CUXOS items on a 5-point ordinal scale using the same rating guideline as the CUDOS. Total scores range from 0 to 80. In the present study, the internal consistency of the CUXOS was 0.91.
The 13-item CUANGOS is a general measure of irritability and aggression. The rating instructions are the same as the CUDOS and CUXOS. Total scores range from 0 to 52. In the present study, the internal consistency of the CUANGOS was 0.91.
The RDQ assesses a broad array of features reported by patients as relevant to determining remission. The domains covered on the RDQ were based on a literature review, our previous study of depressed patients' ratings of the relative importance of 16 factors in determining remission (Zimmerman, McGlinchey, Posternak, & Friedman, 2006) , and two focus groups with depressed patients. In the present study, we used an expanded version of the nonsymptom subscales of the RDQ (coping ability, functioning, well-being, and life satisfaction). We added two items to the coping subscale to make it a 5-item subscale, seven items to the functioning subscale to make it a 10-item subscale, and two items to the well-being and life satisfaction subscale to make it an 8-item subscale. The items refer to the prior week, and are rated on a 3-point rating scale (not at all or rarely true, sometimes true, often or almost always true). The items are scored 0, 1, and 2 with higher item values reflecting greater pathology. In the present study, the internal consistency of the coping subscale was 0.69, the internal consistency of the functioning subscale was 0.68, and the internal consistency of the well-being and life satisfaction subscale was 0.85.
Data analysis
T-tests were used to compare the patients who did and did not meet the DSM-5 anxious distress specifier on continuously distributed variables. Categorical variables were compared by the chi-square statistic. Because multiple tests were conducted we set the alpha level at 0.01 to indicate statistical significance. Odds ratios with 95% confidence intervals were computed to compare the frequency of DSM-5 disorders in the patients who did and did not meet the anxious distress specifier. Where zeros caused problems with the computation of the odds ratio, 0.5 was added to all cells (Anscombe, 1956; Haldane, 1940; Pagano & Gauvreau, 2000) . Hierarchical regression analyses were conducted to determine if the anxious distress specifier was significantly associated with dependent variables after controlling for the presence of an anxiety disorder. We also examined if anxiety disorders were associated with dependent variables after first entering anxious distress subtyping into hierarchical regression models.
TA B L E 1
Demographic characteristics of patients who do and do not meet the DSM-5 criteria for the anxious distress
RESULTS
From August 2015 to January 2018, we recruited the sample, which included 69 (26.5%) men, 182 (70.0%) women, and nine (3.5%) transgender patients, who ranged in age from 18 to 77 years (mean = 38.0,
Approximately one-fifth of the subjects were married (n = 54; 20.1%) and nearly half were single (n = 123; 47.3%). The remainder were divorced (n = 34; 13.1%), separated (n = 10; 3.8%), widowed (n = 7; 2.7%), or living with someone as if in a marital relationship (n = 32; 12.3%). Nearly all of the patients graduated high school or the equivalent (n = 246; 94.6%), and about two-fifths graduated from a 4-year college (n = 110; 42.3%). The racial composition of the sample was 73.9% (n = 192), white, 3.5% (n = 9) black, 10.0% (n = 26) Hispanic, 3.5% (n = 9) Asian, and 9.2% other (n = 24).
Approximately three-quarters of the patients met the DSM-5 anxious distress subtype (n = 203, 78.1%). Neither age nor gender were significantly associated with the anxious distress specifier (Table 1) . The patients who met the specifier were less likely to have graduated from college (Table 1) .
TA B L E 2
The patients who met the anxious distress specifier were significantly more likely to be diagnosed with panic disorder, agoraphobia, and generalized anxiety disorder ( Table 2 ). The patients were also more likely to have been diagnosed with social phobia, specific phobia, posttraumatic stress disorder, and obsessive compulsive disorder but these differences were not significant. The patients who met the anxious distress specifier were significantly more likely to have a drug use disorder, though not an alcohol use disorder.
The patients meeting the anxious distress specifier were more severely depressed, anxious, and irritable than the patients who did not meet specifier criteria (Table 3 ). This was true for both self-report and clinician rated scales. The HAMD includes items assessing both depression and anxiety, and we therefore examined scores on the anxiety-somatization and melancholia subscales as well as the total scale. The patients with anxious distress scored significantly higher on both HAMD subscales as well as the total scale (Table 3 ).
The patients meeting the anxious distress subtype reported poorer functioning during the week before the evaluation (Cohen's d = 0.51; Table 4 ). They also reported poorer coping ability compared to the patients who did not meet the anxious distress specifier (Cohen's d = 0.43). Each of these differences remained significant when conducting an analysis of covariance, controlling for the SADS depressed mood item. There was no difference between groups in episode duration, suicidal ideation, or days missed from work. The patients meeting the anxious distress specifier were not significantly more likely to have a history of psychiatric hospitalization (42.4% vs. 31.6%, 2 = 2.16, n.s.)
or suicide attempt (36.4% vs. 26.3%, 2 = 2.03, n.s.).
We conducted a hierarchical regression analysis to determine if the anxious distress specifier was associated with drug use disorder, impaired functioning (on both the RDQ and the SADS interview), and poorer coping ability, after controlling for the presence of another anxiety disorder. After entering the presence of an anxiety disorder into the model first, the anxious distress specifier was significantly associated with coping scores on the RDQ ( = 0.16, P = 0.023) and functioning scores on the RDQ ( = 0.22, P = 0.003), but not with drug use disorder ( = 0.13, P = 0.074) or past week functioning per the SADS interview ( = 0.14, P = 0.061). When we reversed the order of variable entry into the model and entered the anxious distress specifier before adding the presence of an anxiety disorder, we found that the presence of an anxiety disorder was significantly associated with coping scores on the RDQ ( = 0.26, P < 0.001), but not with drug use disorder ( = 0.14, P = 0.067), functioning scores on the RDQ ( = 0.12, P = 0.106), or past week functioning per the SADS interview ( = 0.01, P = 0.885).
DISCUSSION
The results of the present study indicate that anxious distress is common in depressed patients and support the validity of the DSM-5 anxious distress specifier. Other studies have also found that the majority of depressed patients met criteria for the anxious distress specifier, though the rate was higher in the present study. However, other studies "diagnosed" the anxious distress specifier with scales designed for other purposes and thus did not fully assess all of the anxious distress criteria Melca et al., 2015; Shim et al., 2016) .
The lack of full coverage of the anxious distress criteria could account for the lower frequency. Another study from our group used a selfreport measure of anxious distress in psychiatric outpatients where the level of anxious distress is likely to be lower than in a partial hospital program (Zimmerman, Chelminski, Young, & Dalrymple, 2014) .
However, in a large general population epidemiological study, the rate TA B L E 3 Symptom severity in depressed patients who do and do not meet the DSM-5 criteria for the anxious distress specifier 18.4 11.9 13.0 11.6 2.89** SADS, Schedule of Affective Disorders and Schizophrenia; CUXOS, Clinically Useful Anxiety Outcome Scale; HAMA, Hamilton Anxiety Rating Scale; HAMD, Hamilton Depression Rating Scale; CUDOS, Clinically Useful Depression Outcome Scale; CUANGOS, Clinically Useful Anger Outcome Scale. *P < 0.05; **P < 0.01; ***P < 0.001. a Anxious distress present, n = 184; anxious distress absent, n = 53-54. b Anxious distress present, n = 202; anxious distress absent, n = 56.
TA B L E 4 Psychosocial morbidity in depressed patients who do and do not meet the DSM-5 criteria for the anxious distress specifier

Anxious distress present (n = 203)
Anxious distress absent (n = 57) of anxious distress in the individuals who experienced a lifetime major depressive episode (74.6%) was nearly as high as in the present study (Hasin, Sarvet, Meyers, & Saha, 2018) . Future studies should use a standardized interview to evaluate the anxious distress specifier.
Morbidity indicator
We found that anxious distress was associated with a higher frequency of anxiety disorders, particularly panic disorder and generalized anxiety disorder. This association is not surprising because of the overlap in symptom criteria. Three of the anxious distress specifier criteria overlap with criteria for generalized anxiety disorder (feeling keyed up or tense, feeling restless, difficulty concentrating because of worry) and one criterion overlaps with a criterion for panic disorder (feeling that one might lose control). Both and Gaspersz, Lamers, Kent, and Beekman (2017b) also found significantly elevated rates of panic disorder and generalized anxiety disorder in patients who met the anxious distress specifier.
Similar to other studies of the anxious distress specifier, symptom severity, in general, was greater in the patients who met the anxious distress specifier (Gaspersz et al., 2017b; . This is consistent with our previous study examining the anxious distress specifier as a cross-sectional dimensional measure, which found that scores on the DADSI were significantly correlated with symptom severity measures of anxiety, depression, and anger . The significant association of these three mood states is consistent with the inclusion of irritability as a diagnostic criterion for generalized anxiety disorder, as well as studies showing that the patients with high levels of anger have increased rates of anxiety disorders (Genovese, Dalrymple, Chelminski, & Zimmerman, 2017) , patients with depression have elevated rates of anxiety disorders (Klein-Hofmeijer Sevink, Batelaan, van Megen, & Penninx, 2012; Melartin, Rytsala, Leskela, & Lestela-Mielonen, 2002; Zimmerman, McDermut, & Mattia, 2000) , and patients with anxiety disorders have elevated rates of depression and anger (Regier, Narrow, Rae, & Manderscheid, 1993) .
In the present study, the patients with anxious distress were more frequently diagnosed with a drug use disorder and reported significantly poorer functioning and coping ability. This is consistent with other studies finding that depressed patients with comorbid anxiety disorders or high levels of anxiety have poorer functioning (Klein-Hofmeijer Sevink et al., 2012; and an increased frequency of substance use disorders (Howland, Rush, Wisniewski, & Trivedi, 2009) . Although the effect sizes for the differences in coping and functioning were small to medium, that these differences were found at all in a relatively severely ill patient group presenting to a partial hospital program is noteworthy.
We did not find that anxious distress was associated with retrospectively reported episode duration. Using a prospective design, two reports by Gaspersz et al. (2017a Gaspersz et al. ( , 2017b found that the presence of anxious distress predicted poorer outcome. Moreover, they found that the anxious distress specifier outperformed DSM-IV anxiety disorder diagnoses in predicting longitudinal course.
The anxious distress specifier entered DSM-5 in the absence of prior research on its empirical validity or clinical utility. Rather, the research demonstrating the importance of anxiety in depressed patients was based on the diagnosis of an anxiety disorder or an elevated score on a dimensional measure. Most treatment studies have used the HAMD anxiety/somatization factor to determine the presence or absence of high anxiety. Some studies found that high anxiety predicts poorer response to treatment (Fava et al., 2008; Howland et al., 2009; Papakostas & Larsen, 2011) and differential response to medication (Davidson et al., 2002; Papakostas et al., 2008) , whereas other studies have not found an association between pretreatment anxiety and treatment response (Nelson, 2010) or differential treatment response (Russell et al., 2001; Simon et al., 1998) .
Although scores on the HAMD anxiety/somatization factor are significantly higher in patients who meet the anxious distress specifier compared to patients who do not meet the specifier, the two methods of subtyping patients are only modestly associated (Zimmerman et al., 2018) . Thus, the treatment implications of the DSM-5 anxious distress specifier cannot be extrapolated from studies based on the HAMD anxiety/somatization factor. DSM-5, like its predecessors, includes criteria for a number of specific anxiety disorders that can be diagnosed in patients with MDD.
Consequently, as a new diagnostic entity, the anxious distress specifier should demonstrate either an improvement in validity or clinical utility over and above what is already established in the DSM. Toward this end, we found that the presence of anxious distress was associated with poorer coping and functioning after controlling for the presence of an anxiety disorder. This suggests improved construct validity. However, we also found that the presence of an anxiety disorder was associated with poorer coping after controlling for the presence of anxious distress. This suggests that anxious distress is not redundant with diagnosing an anxiety disorder as both capture unique variance with external variables.
Before concluding, the limitations of the present study should be recognized. The study was conducted in a single clinical practice in which the majority of the patients were white, female, and had health insurance. Replication in samples with different demographic characteristics is warranted. It will also be important to replicate these findings in an outpatient sample and to continue to examine the association between the DSM-5 specifier and anxiety disorder diagnoses and whether each is independently associated with external validators. Finally, the internal consistency of the RDQ coping and functioning subscales was modest, although this would not account for the significant findings in the present study. 
